South Korea approves cloning research
By Agence France-Presse,
Agence France-Presse
| 01. 12. 2005
SEOUL (AFP) - South Korea (news - web sites) gave official government backing to ground-breaking research that produced the world's first cloned human embryos.
The health and welfare ministry said a research team led by Hwang Woo-Seok, a Seoul National University professor, has been officially registered as a state institute and its research approved.
"Professor Hwang Woo-Seok's team will now be able to step up its research on stem cells under the government's management system," the ministry said in a statement.
In February 2004, Hwang's cutting edge research produced the first cloned human embryos to generate stem cells for therapeutic purposes.
Stem cells hold the key to potential cures for an array of diseases including diabetes, cancer, Alzheimer's and other disorders.
New legislation that took effect here on January 1 requires all bio-technology institutes to register with the government.
The legislation offers government support but also tightens government control in the ethically-sensitive field of human embryos research. South Korea last year banned the cloning of human beings and also bans stem cell research for commercial purposes.
Stem cells are nascent...
Related Articles
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Jennifer Takhar, Carolyn Wilson-Nash, and Chloe He, BioNews | 06.22.2026
Imagine wanting to have a child and discovering, at every stage, that the system was not designed with you in mind. This is the reality for many LGBTQ+ people in the UK who seek fertility treatment each year.
Our study...
By Arche Noah, GMWatch | 06.17.2026
The European Parliament has voted for a wide-reaching deregulation of New Genomic Techniques (NGTs). There was no majority for amendments stopping patents on conventionally classically bred plants or NGT plants. “Today’s vote is a missed opportunity to protect Europe’s farmers...
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...